Frontera Therapeutics

Committed to Advancing Human Health

Bedford, United States · Founded 2019 · $195.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$195.0M
Last Round
$160.0M Series BJun 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Frontera Therapeutics develops innovative, high-quality, affordable rAAV gene therapies for patients worldwide. Its pipeline addresses significant unmet needs in large-market and rare ophthalmology and cardiology diseases, with several programs in or through Phase II clinical trials. The company combines AAV capsid and gene-expression cassette engineering with scalable production, purification, analytical testing, and an integrated quality-control system at its GMP manufacturing facility.

Summary

Frontera Therapeutics is a Biotech company based in Bedford, United States, founded in 2019. It has raised $195.0M in total across 2 rounds, most recently a $160.0M Series B round in Jun 2022. Investors include OrbiMed, Creacion Ventures and Boyu Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2022
$160.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Frontera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/frontera-therapeutics"><img src="https://indexed.vc/api/badge/company/frontera-therapeutics" alt="Frontera Therapeutics on Indexed.vc" width="260" height="76" /></a>